Immunology
-
Ragifilimab Biosimilar (GITR/TNFRSF18) Antibody (HDBS0063)
system_update_altDatasheetRagifilimab Biosimilar (GITR/TNFRSF18) Antibody (HDBS0063)The Anti-GITR (TNFRSF18) Polyclonal Antibody (HDBS0063) is a vital tool for researchers -
Relatlimab Biosimilar (LAG3) Antibody (HDBS0060)
system_update_altDatasheetRelatlimab Biosimilar (LAG3) Antibody (HDBS0060)The Lag3 Relatli Biosimilar (HDBS0060) is a cutting-edge product designed for researchers studyin -
Denosumab Biosimilar (TNFSF11) Antibody (HDBS0057)
system_update_altDatasheetDenosumab Biosimilar (TNFSF11) Antibody (HDBS0057)The TNFSF11 (Denosu) Biosimilar (HDBS0057) is a highly specialized biologic medication designed -
Adalimumab Biosimilar (TNFa) Antibody (HDBS0055)
system_update_altDatasheetAdalimumab Biosimilar (TNFa) Antibody (HDBS0055)The TNFA (Adalimu Biosimilar) Antibody (HDBS0055) is a high-quality, research-grade antibody desi -
Cabiralizumab Biosimilar (CSF1R) Antibody (HDBS0054)
system_update_altDatasheetCabiralizumab Biosimilar (CSF1R) Antibody (HDBS0054)The CSF1R Cabiralizu Biosimilar (HDBS0054) is a cutting-edge monoclonal antibody designed for -
Icatolimab Biosimilar (BTLA) Antibody (HDBS0053)
system_update_altDatasheetIcatolimab Biosimilar (BTLA) Antibody (HDBS0053)The BTLA (ICAToli Biosimilar) Antibody (HDBS0053) is a high-quality research tool designed for st -
Dupilumab Biosimilar (IL-4RA) Antibody (HDBS0051)
system_update_altDatasheetDupilumab Biosimilar (IL-4RA) Antibody (HDBS0051)The IL-4RA (Dupilumab Biosimilar) Antibody (HDBS0051) is a cutting-edge research tool designed f -
Inebilizumab Biosimilar (CD19) Antibody (HDBS0050)
system_update_altDatasheetInebilizumab Biosimilar (CD19) Antibody (HDBS0050)The CD19 Inebilizu Biosimilar (HDBS0050) is a targeted therapy designed to inhibit immune respo -
Magrolimab Biosimilar, Igg1 Biosimilar (CD47) Antibody (HDBS0049)
system_update_altDatasheetMagrolimab Biosimilar, Igg1 Biosimilar (CD47) Antibody (HDBS0049)The CD47 Magroli Biosimilar (HDBS0049) is a cutting-edge product developed by As -
-
-
